Sumitomo Mitsui Trust Group, Inc. 13D and 13G filings for Seres Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-04 06:09 am Sale | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | Sumitomo Mitsui Trust Group, Inc. | 785,519 0.850% | -5,038,084 (-86.51%) | Filing |
| 2021-02-05 06:10 am Purchase | 2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB | Sumitomo Mitsui Trust Group, Inc. | 5,823,603 6.380% | 198,613 (+3.53%) | Filing |
| 2020-09-09 06:03 am Sale | 2020-08-31 | 13G | Seres Therapeutics, Inc. MCRB | Sumitomo Mitsui Trust Group, Inc. | 5,624,990 6.300% | -2,648,233 (-32.01%) | Filing |